Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DMSO + water refers to a combination of dimethyl sulfoxide (DMSO) and water, typically used as an aqueous solution. DMSO is a highly polar organic solvent with notable biological properties, including anti-inflammatory and analgesic effects. In medicine, DMSO is primarily approved for intravesical use in the treatment of interstitial cystitis (painful bladder syndrome), where it is instilled into the bladder as a diluted aqueous solution[7][8]. The addition of water serves to dilute DMSO to concentrations appropriate for medical or laboratory use; common clinical concentrations range from 10% to 50% DMSO in water[1][4]. This combination enhances tissue penetration and can facilitate the delivery of other drugs through biological membranes due to DMSO’s carrier properties[5]. Outside its approved indication, topical or intravenous formulations are sometimes used off-label for conditions such as musculoskeletal pain or amyloidosis, but evidence supporting these uses remains limited and unapproved by regulatory agencies[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dmso + water.